T cells detect peptide fragments displayed on cell surfaces through a specialized receptor and a coordinated presentation system. The T cell receptor binds short peptides lodged in the groove of a Major Histocompatibility Complex molecule on antigen-presenting cells. This structural partnership limits recognition to peptides presented by a host's own MHC molecules, a principle established by Peter Doherty and Rolf Zinkernagel at the University of Melbourne who demonstrated MHC restriction. Pamela Bjorkman at the California Institute of Technology resolved the three-dimensional structure of class I MHC, revealing the peptide-binding groove that enables diverse peptide capture. Together these findings explain how a T cell inspects fragments of proteins rather than whole pathogens, converting intracellular and extracellular information into a surface-displayed code the immune system can read.
Generation of TCR diversity
The capacity of the T cell repertoire to recognize millions of distinct peptide-MHC combinations stems from somatic rearrangement of receptor genes. Susumu Tonegawa at the Massachusetts Institute of Technology uncovered the general mechanism of somatic gene rearrangement that creates receptor diversity, known as V(D)J recombination. Mark M. Davis at Stanford University and colleagues characterized the T cell receptor genes themselves, showing how different variable, joining, and constant gene segments combine and how alpha and beta chains pair to produce unique binding surfaces. Junctional modifications and combinatorial pairing amplify diversity beyond the number of germline gene segments, allowing a small set of genes to generate an extremely large repertoire of unique receptors.
Selection and outcomes
Diversity is tempered by thymic education, a process that ensures responsiveness to foreign peptides while limiting self-reactivity. Immature T cells in the thymus undergo positive selection to ensure they can recognize self-MHC and negative selection to eliminate strongly self-reactive clones. These selection steps create a functional balance so that most peripheral T cells will respond to foreign peptides presented on self-MHC without causing widespread autoimmunity. Failures or variations in selection contribute to autoimmune disease, transplant rejection, or immunodeficiency.
Recognition has practical consequences across medicine and society. HLA polymorphism in human populations influences susceptibility to infectious diseases, vaccine responsiveness, and the difficulty of finding compatible organ donors, with implications for different ethnic and territorial groups. Therapeutic manipulation of T cell recognition underpins modern cancer immunotherapy. James P. Allison at the University of Texas MD Anderson Cancer Center translated understanding of T cell activation checkpoints into CTLA-4 blockade, demonstrating that releasing inhibitory brakes on T cells can produce durable anti-tumor responses.
The interplay of structural specificity, genetic rearrangement, and developmental selection explains how T cells recognize a vast array of antigens while preserving self-tolerance. This system reflects evolutionary trade-offs: powerful adaptive recognition that must be carefully regulated to avoid collateral damage, shaped by human genetic diversity and by environmental and cultural factors that influence exposure to pathogens, vaccination practices, and clinical approaches to transplantation and immunotherapy.